Colon Cancer Biomarkers | Know Your Biomarker

Biomarker Facts

What are biomarkers and how are they used in colorectal cancer? Learn about biomarkers, their role in personalized medicine, and their impact on your treatment.

fact about colorectal cancer biomarkers

Biomarker treatment impact tables diagram

Biomarker Overview and Treatment Impact Table

Learn about different colorectal cancer biomarkers and how they affect your treatment options.

Biomarkers

Colorectal Cancer Biomarkers

Learn about the BRAF biomarker and how it affects your colorectal cancer targeted therapy options.

Learn about the carcinoembryonic antigen (CEA) biomarker and how it is used in the diagnosis, monitoring, and treatment of your colorectal cancer.

Learn how ctDNA and liquid biopsy are used in your colorectal cancer biomarker testing, treatment response monitoring, and diagnosis of cancer recurrence.

Learn about HER2 amplification / over expression and what it means for your colorectal cancer treatment.

Learn about the KRAS biomarker and how it affects your colorectal cancer targeted therapy options.

Learn about microsatellite instability (MSI, MSI-High, MSI-H) and how it affects your colorectal cancer treatment options.

Learn about microsatellite stability (MSS) and how it affects your colorectal cancer treatment options.

Learn about the NRAS biomarker and how it affects your colorectal cancer targeted therapy options.

Learn about NTRK fusion and how it can be a treatment target in the management of your colorectal cancer.

Learn about the PIK3CA biomarker and how it affects your colorectal cancer targeted therapy options.

Learn about how right-sided colon cancer and left-sided colorectal cancer are different and how that affects your prognosis and treatment.

Learn about tumor mutational burden (TMB) and how it affects your colorectal cancer treatment options.

Syndromes

Colorectal Cancer Syndromes

Learn about Familial Adenomatous Polyposis (FAP), an inherited genetic colorectal cancer syndrome, and how it affects you and your family.

Learn about Lynch Syndrome, also known as Hereditary Nonpolyposis Colorectal Cancer (HNPCC), a cancer syndrome caused by deficient DNA mismatch repair (dMMR).

Biomarkers

Toxicity Biomarkers

Learn about the DPYD biomarker and fluorouracil (5-FU) treatment toxicity in colorectal cancer.

Learn about the UGT1A1 biomarker and irinotecan treatment toxicity in colorectal cancer.